CEO and Founder, CureOne
Director, Precision Medicine Policy and Registries, Oregon Health Science University
Dr. Dickson is a medical oncologist practicing in rural Idaho. He served as the Director of Clinical Science at Palmetto’s MolDX program (where he helped advance precision medicine through novel coverage approaches for molecular testing) and now serves as the chief executive officer of the nonprofit CureOne (formerly MED-C). CureOne has launched the N1 Registry which enables payors to cover next generation sequencing through independent standardization and quality verification through outcome collection at a low cost to laboratories. He also is the Director of Precision Medicine Policy at the Knight Cancer Institute at Oregon Health Science University, where he serves as adjunct faculty.
Dr. Dickson has been an active member of the American Society of Clinical Oncology (ASCO), serving on the Clinical Practice Committee and State Affiliate Council. He was president of Idaho Society of Clinical Oncology (ISCO) and served on the executive sub-committee of the ASCO State Affiliate Council.